Visualized analysis and evaluation of simultaneous controlled release of metformin hydrochloride and gliclazide from sandwiched osmotic pump capsule

References

• Bell S, Farran B, McGurnaghan S, et al. Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study. BMC Nephrol. 2017;18:163.
   PubMed Web of Science ®Google Scholar
• Yang XL, Duo-Ji MM, Long ZW. Efficacy and safety of single- or double-drug antidiabetic regimens in the treatment of type 2 diabetes mellitus: a network meta-analysis. J Cell Biochem. 2017;118:4536–4547.
   PubMed Web of Science ®Google Scholar
• Zabielski P, Hady HR, Chacinska M, et al. The effect of high fat diet and metformin treatment on liver lipids accumulation and their impact on insulin action. Sci Rep. 2018;8:7249.
   PubMed Web of Science ®Google Scholar
• Zabielski P, Chacinska M, Charkiewicz K, et al. Effect of metformin on bioactive lipid metabolism in insulin-resistant muscle. J Endocrinol. 2017;233:329–340.
   PubMed Web of Science ®Google Scholar
• Leiter LA, Shestakova MV, Satman I. Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial. Diabetol Metab Syndr. 2018;10:30.
   PubMed Web of Science ®Google Scholar
• Elshafeey AH, Elsherbiny MA, Fathallah MMA. Single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions. Clin Ther. 2009;31:600–608.
   PubMed Web of Science ®Google Scholar
• Defang O, Shufang N, Wei L, et al. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Dev Ind Pharm. 2005;31:677–685.
   PubMed Web of Science ®Google Scholar
• Ouyang D, Nie S, Li W, et al. Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets. J Pharm Pharmacol. 2005;57:817–820.
   PubMed Web of Science ®Google Scholar
• Cho HY, Yoon H, Lim YC, et al. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects. Int J Clin Pharmacol Ther. 2009;47:770–779.
   PubMed Web of Science ®Google Scholar
• Kalra S, Das AK. Epidemiologic surveillance of glycemic response to a scored, breakable, extended release, fixed dose combination of gliclazide and metformin in persons with type 2 diabetes. J Assoc Physicians India. 2017;65:38–41.
   PubMedGoogle Scholar
• Bhaskar R, Bhaskar R, Sagar MK, et al. Multivariate chemometric assisted analysis of metformin hydrochloride, gliclazide and pioglitazone hydrochloride in bulk drug and dosage forms. Adv Pharm Bull. 2013;3:79–84.
   PubMedGoogle Scholar
• Xue Y, Yu S, Wang H, et al. Design of a timed and controlled release osmotic pump system of atenolol. Drug Dev Ind Pharm. 2015;41:906–915.
   PubMed Web of Science ®Google Scholar
• Hill A, Breyer S, Geissler S, et al. How do in-vitro release profiles of nanosuspensions from Alzet® pumps correspond to the in-vivo situation? A case study on radiolabeled fenofibrate. J Control Release. 2013;168:77–87.
   PubMed Web of Science ®Google Scholar
• Ma C, Huang Z, Zhu Y, et al. Production and in vitro evaluation of a lamotrigine extended release tablet based on a controlled-porosity osmotic pump system. Pharmazie. 2017;72:511–517.
   PubMed Web of Science ®Google Scholar
• Theeuwes F. Elementary osmotic pump. J Pharm Sci. 1975;64:1987–1991.
   PubMed Web of Science ®Google Scholar
• Theeuwes F, Swanson D, Wong P, et al. Elementary osmotic pump for indomethacin. J Pharm Sci. 1983;72:253–258.
   PubMed Web of Science ®Google Scholar
• Alam N, Beg S, Rizwan M, et al. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability. Drug Dev Ind Pharm. 2015;41:692–702.
   PubMed Web of Science ®Google Scholar
• Nakajima T, Takeuchi I, Ohshima H, et al. Push-pull controlled drug release systems: effect of molecular weight of polyethylene oxide on drug release. J Pharm Sci. 2018;107:1896–1902.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhao ZY, Chen DW, et al. Co-delivery of resveratrol and docetaxel via polymeric micelles to improve the treatment of drug-resistant tumors. Asian J Pharm Sci. 2019;14:78–85.
   PubMed Web of Science ®Google Scholar
• Kumaravelrajan R, Narayanan N, Suba V, et al. Simultaneous delivery of Nifedipine and Metoprolol tartarate using sandwiched osmotic pump tablet system. Int J Pharm. 2010;399:60–70.
   PubMed Web of Science ®Google Scholar
• Jin D, Wang B, Hu R, et al. A novel colon-specific osmotic pump capsule of panax notoginseng saponins (PNS): formulation, optimization, and in vitro-in vivo evaluation. AAPS PharmSciTech. 2018;19:2322–2329.
   PubMed Web of Science ®Google Scholar
• Qin C, He W, Zhu C, et al. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet. Int J Pharm. 2014;466:276–285.
   PubMed Web of Science ®Google Scholar
• Wu L, Yin X, Guo Z, et al. Hydration induced material transfer in membranes of osmotic pump tablets measured by synchrotron radiation based FTIR. Eur J Pharm Sci. 2016;84:132–138.
   PubMed Web of Science ®Google Scholar
• Keraliya RA, Patel C, Patel P, et al. Osmotic drug delivery system as a part of modified release dosage form. ISRN Pharm. 2012;2012:528079.
   PubMedGoogle Scholar
• Bhatt B, Kumar V. Regenerated cellulose capsules for controlled drug delivery, part 2: modulating membrane permeability by incorporation of depolymerized cellulose and altering membrane thickness. J Pharm Sci. 2015;104:4266–4275.
   PubMed Web of Science ®Google Scholar
• Bhatt B, Kumar V. Regenerated cellulose capsules for controlled drug delivery: part IV. In-vitro evaluation of novel self-pore forming regenerated cellulose capsules. Eur J Pharm Sci. 2017;97:227–236.
   PubMed Web of Science ®Google Scholar
• Bhatt B, Kumar V. Regenerated cellulose capsules for controlled drug delivery: part III. Developing a fabrication method and evaluating extemporaneous utility for controlled-release. Eur J Pharm Sci. 2016;91:40–49.
   PubMed Web of Science ®Google Scholar
• Li Z, Sun Z, Duan Z, et al. Super-hydrophobic silver-doped TiO2 @ polycarbonate coatings created on various material substrates with visible-light photocatalysis for self-cleaning contaminant degradation. Sci Rep. 2017;7:42932.
   PubMed Web of Science ®Google Scholar
• Arno EA, Anand P, Bhaskar K, et al. Eudragit NE30D based metformin/gliclazide extended release tablets: formulation, characterisation and in vitro release studies. Chem Pharm Bull. 2002;50:1495–1498.
   PubMed Web of Science ®Google Scholar
• Pillay V, Fassihi R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J Control Release. 1998;55:45–55.
   PubMed Web of Science ®Google Scholar
• Shah VP, Tsong Y, Sathe P, et al. In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2. Pharm Res. 1998;15:889–896.
   PubMed Web of Science ®Google Scholar
• Lin HP, Sun D, Zhang X, et al. Physiologically based pharmacokinetic modeling for substitutability analysis of venlafaxine hydrochloride extended-release formulations using different release mechanisms: osmotic pump versus openable matrix. J Pharm Sci. 2016;105:3088–3096.
   PubMed Web of Science ®Google Scholar
• Al-Rimawi F. Development and validation of an analytical method for metformin hydrochloride and its related compound (1-cyanoguanidine) in tablet formulations by HPLC-UV. Talanta. 2009;79:1368–1371.
   PubMed Web of Science ®Google Scholar
• Paul D, Allakonda L, Satheeshkumar N. A validated UHPLC-QTOF-MS method for quantification of metformin and teneligliptin in rat plasma: application to pharmacokinetic interaction study. J Pharm Biomed Anal. 2017;143:1–8.
   PubMed Web of Science ®Google Scholar
• Resztak M, Hermann T, Sawicki W, et al. Pharmacokinetics and pharmacodynamics of gliclazide from immediate and modified release formulation tablets in rats. Iran J Pharm Res. 2014;13:29–37.
   PubMed Web of Science ®Google Scholar
• Viana I. M d O, Lima P. d P R, Soares CDV, et al. Simultaneous determination of oral antidiabetic drugs in human plasma using microextraction by packed sorbent and high-performance liquid chromatography. J Pharm Biomed Anal. 2014;96:241–248.
   PubMed Web of Science ®Google Scholar
• Yu LF, Hu RF, Su D, et al. Characterizing flowability of microcrystalline cellulose and its visualizing the correlation of the performance parameters. Acta Pharmaceutica Sinica. 2018;53:806–811.
   Google Scholar
• Kumar A, Kumar Philip A, Pathak K. Asymmetric membrane capsules of phenylephrine hydrochloride: an osmotically controlled drug delivery system. CDD. 2011;8:474–482.
   PubMed Web of Science ®Google Scholar
• Siahi-Shadbad MR, Asare-Addo K, Azizian K, et al. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers. AAPS PharmSciTech. 2011;12:1176–1182.
   PubMed Web of Science ®Google Scholar
• Huang J, Lin H, Peng B, et al. Design and evaluation of hydrophilic matrix system for pH-independent sustained release of weakly acidic poorly soluble drug. AAPS PharmSciTech. 2018;19:2144–2154.
   PubMed Web of Science ®Google Scholar
• Cheng L, Li T, Dong L, et al. Design and evaluation of bilayer pump tablet of flurbiprofen solid dispersion for zero-order controlled delivery. J Pharm Sci. 2018;107:1434–1442.
   PubMed Web of Science ®Google Scholar
• Li YN, Pan H, Duan HL, et al. Double-layer osmotic pump controlled release tablets of actarit: in vitro and in vivo evaluation. Asian J Pharm Sci. 2019;14:340–380.
   PubMed Web of Science ®Google Scholar
• Wen H, Li X, Li Y, et al. In vitro and in vivo evaluation of controlled-release matrix tablets of highly water-soluble drug applying different mw polyethylene oxides (PEO) as retardants. Drug Dev Ind Pharm. 2018;44:544–552.
   PubMed Web of Science ®Google Scholar
• Zhao S, Yu F, Liu N, et al. Synchronous delivery of felodipine and metoprolol tartrate using monolithic osmotic pump technology. Drug Dev Ind Pharm. 2016;42:1723–1731.
   PubMed Web of Science ®Google Scholar